BARREGEN ESOPHAGEAL CANCER RISK CLASSIFIER
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 03 Dec 2022)
What this means for you
Registered since 23 May 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86910938
- Registration number
- 5210362
- Mark type
- Design + words
- Filed
- 17 Feb 2016
- Published for opposition
- 19 Jul 2016
- Registered
- 23 May 2017
- Attorney of record
- Jeanne Hamburg
Goods and services
- Class 044 — Medical, beauty and agricultural services: Medical diagnostic molecular testing, monitoring and reporting services to aid in the diagnosis and mitigation of esophageal cancer
Owner
- Interpace Diagnostics, LLC, Parsippany, NJ, US
- Interpace Diagnostics, LLC, Parsippany, NY, US
- Interpace Diagnostics, LLC, Parsippany, NY, US
Prosecution history
- 08 Sept 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Sept 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Sept 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Sept 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 08 Sept 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 03 Dec 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 03 Dec 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 03 Dec 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 May 2022 — TEAS SECTION 8 & 15 RECEIVED
- 23 May 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Feb 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 May 2017 — REGISTERED-PRINCIPAL REGISTER
- 20 Apr 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Apr 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Feb 2017 — NOTIFICATION OF NON-FINAL ACTION E-MAILED